Tatva Chintan Pharma Chem Limited IPO
MainboardChemicals
Listed On: Jul 29, 2021 at ₹ 2111.85(NSE)
₹ 14079 /13 Shares
Check Allotment16 Jul, 2021
Open Date20 Jul, 2021
Close Date26 Jul, 2021
Allotment Date29 Jul, 2021
Listing DatePrice Summary
Last Closing
1,408.00 (30.01%)52 Week High
1,610.0052 Week Low
621.00Last Update
19-Dec-2025 3:30 PMIPO Issue Details
- Issue Price ₹1073-1083 per equity share
- Face Value ₹10 Per Equity Share
- Issue Price 500 Cr(225 Cr Fresh Issue + 275 Cr Offer for Sale)
- Listing at BSE, NSE
- List Price 2111.85(NSE)
- Listing Date 2021-07-29
- Lead Manager ICICI Securities Limited, JM Financial Consultants Private Limited
- Registrar Link Intime India Private Ltd
IPO Details
- Retail Portion 35%
IPO Details
The IPO of is priced at ₹1073-1083 per equity share, which has a face value of ₹10 Per Equity Share each, IPO bidding starts from Jul 16, 2021 and ends on Jul 20, 2021. The allotment for IPO will be finalized on Jul 26, 2021. IPO will be listed on BSE, NSE, with a tentative listing date fixed as Jul 29, 2021. The company shall list its equity shares on the BSE, NSE. Link Intime India Private Ltd is the registrar of the issue.
The book-running lead manager for the IPO is/are ICICI Securities Limited, JM Financial Consultants Private Limited.
The IPO sets its price band at 1073-1083 for each share. A single application for Tatva Chintan Pharma Chem Limited IPO must contain at least 13 shares.
Read More
IPO Subscription Analysis And Details
| As on | QIB | NII | Retail | Total |
|---|---|---|---|---|
| Shares Offered / Reserved | 9,31,966 | 6,98,975 | 16,30,941 | 32,61,882 |
|
Day 1
16-07-20 05:00 PM
|
0.51 x | 1.13 | 8.25 x | 4.51 x |
|
Day 2
19-07-20 05:00 PM
|
1.97 x | 12.21 | 23.74 x | 15.05 x |
|
Day 3
20-07-20 05:00 PM
|
186.96 x | 516.99 | 35.67 x | 182.04 x |
Valuations
Company Financials
| 31-Mar-21 | 31-Mar-20 | 31-Mar-19 | 31-Mar-18 | |
|---|---|---|---|---|
| Assets | 314.80 | 248.94 | 187.51 | 143.72 |
| Revenue | 306.29 | 264.62 | 206.8 | 137.29 |
| Profit After Tax | 52.26 | 37.79 | 20.54 | 12.29 |
About Company
Incorporated in 1996, Tatva Chintan Pharma Chem Limited is a chemical manufacturing company that manufactures structure directing agents (SDAs), phase transfer catalyst (PTCs), pharmaceutical and agrochemical intermediates, and other specialty chemicals. It is among the largest manufacturer of SDAs for zeolites in India.
The company serves customers across industries i.e. automotive, petroleum, agrochemicals, dyes and pigments, paints and coatings, pharmaceutical, personal care, and others. Its products are not only sold in India but also export to 25+ countries all over the world such as the USA, Germany, South Africa, China, and the UK. In FY 2020, total export contributed to 76% of total revenue from operations.
Merck, Bayer AG, Ipox Chemicals, Laurus labs, Navin Fluorine International Limited, Atul Limited, Otsuka Chemicals, SRF Limited, Hawks Chemical Company, Firmenich Aromatics Prod Pvt Ltd, and Divi's laboratories are a few of customers of the company. Currently, it has two manufacturing facilities at Ankleshwar and Dahej in Gujarat.
- Promoter(s)
Ajaykumar Mansukhalal Patel
Chintan Nitinkumar Shah
Shekhar Rasiklal Somani
Pre Issue Share Holding : 100%
Post Issue Share Holding : 79.17%
IPO - Issue Objectives
Funding capital expenditures requirements for expansion of Dahej manufacturing facility.
Funding capital expenditures requirements to upgrade R&D facilities in Vadodara.
To meet general corporate purposes.
IPO - Anchor Investors
Tatva Chintan Pharma Chem mobilises Rs 150 crore from anchor investors ahead of IPO
Marquee global investors who participated in the anchor book were Goldman Sachs, HSBC Global, Abu Dhabi Investment Authority, Aberdeen Standard Asia, and Nomura.
Axis MF, Aditya Birla Sun Life, Nippon Life, SBI Life Insurance, SBI MF, ICICI Prudential, and HDFC Trustee are among domestic investors invested in the specialty company through anchor book.
IPO - Peers Comparison
| P/B Ratio | P/E Ratio | RoNW | Revenue(in Cr.) | |
|---|---|---|---|---|
| Tatva Chintan Pharma Chem Limited | 13.11 | 45.80 | 31.49% | 306.29 Cr |
| Aarti Industries Limited | 7.79 | 28.46 | 15.05% | 4,506.80 Cr |
| Navin Fluorine International Limited | 11.62 | 73.63 | 18.13% | 1,258.43 Cr |
| Alkyl Amines | 9.48 | 26.40 | 37.27% | 1,249.38 Cr |
| Vinati Organics | 12.88 | 73.58 | 17.45% | 980.10 Cr |
| Fine Organics Industries | 12.64 | 78.47 | 15.56% | 294.41 Cr |
IPO - FAQs
Ans. Tatva Chintan Pharma Chem Limited IPO is a Mainboard IPO. The issue is priced at ₹1073-1083 per equity share. The minimum order quantity is 13 Shares. The IPO opens on Jul 16, 2021, and closes on Jul 20, 2021. Link Intime India Private Ltd is the registrar for the IPO. The shares are proposed to be listed on BSE, NSE.
Ans. The Tatva Chintan Pharma Chem Limited IPO opens on Jul 16, 2021 and closes on Jul 20, 2021.
Ans. You can track the real-time subscription numbers using the links below:
Ans. The size of Tatva Chintan Pharma Chem Limited IPO is 500 Cr(225 Cr Fresh Issue + 275 Cr Offer for Sale).
Ans. The Tatva Chintan Pharma Chem Limited IPO price band is set between ₹1073-1083 per equity share.
Ans. To apply for Tatva Chintan Pharma Chem Limited IPO, follow the steps given below:
- - Open the IPO Ji App or Website
- - Find Tatva Chintan Pharma Chem Limited IPO in the List of IPOs
- - Press Apply Button
- - Select Your Demat Account
- - Select Your Shares Quantity and Submit
- - Track Your IPO Status
Ans. The share allotment date of Tatva Chintan Pharma Chem Limited IPO is Jul 26, 2021.
Ans. The Tatva Chintan Pharma Chem Limited IPO will be listed on Jul 29, 2021.
Ans. Follow the steps to check the Tatva Chintan Pharma Chem Limited IPO allotment status online.
